Evidence map›Paper›PMID 31148579›Full record

ArticleScientific reports2019

CSN5 inhibition triggers inflammatory signaling and Rho/ROCK-dependent loss of endothelial integrity.

Jisca Majolée, Manon C A Pronk, Kin K Jim, Jan S M van Bezu, Astrid M van der Sar, Peter L Hordijk, Igor Kovačević

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. [Differential expression of NEDD8 in different pathological types of chronic rhinosinusitis with nasal polyps].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2023
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. The pivotal roles of neddylation pathway in immunoregulation.Immunity, inflammation and disease · 2020
    Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jisca MajoléeAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Physiology, Amsterdam Cardiovascular Sciences, De Boelelaan 1117, 1081HZ, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-4450-3948
Manon C A PronkAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Physiology, Amsterdam Cardiovascular Sciences, De Boelelaan 1117, 1081HZ, Amsterdam, The Netherlands.
Kin K JimAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Microbiology and Infection Control, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, 1081HZ, Amsterdam, The Netherlands.
Jan S M van BezuAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Physiology, Amsterdam Cardiovascular Sciences, De Boelelaan 1117, 1081HZ, Amsterdam, The Netherlands.
Astrid M van der SarAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Microbiology and Infection Control, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, 1081HZ, Amsterdam, The Netherlands.
Peter L HordijkAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Physiology, Amsterdam Cardiovascular Sciences, De Boelelaan 1117, 1081HZ, Amsterdam, The Netherlands.
Igor KovačevićAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Physiology, Amsterdam Cardiovascular Sciences, De Boelelaan 1117, 1081HZ, Amsterdam, The Netherlands. i.kovacevic@vumc.nl.ORCID http://orcid.org/0000-0003-1834-2378
Amsterdam University Medical Centers · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RhoGTPases regulate cytoskeletal dynamics, migration and cell-cell adhesion in endothelial cells. Besides regulation at the level of guanine nucleotide binding, they also undergo post-translational modifications, for example ubiquitination. RhoGTPases are ubiquitinated by Cullin RING ligases which are in turn regulated by neddylation. Previously we showed that inhibition of Cullin RING ligase activity by the neddylation inhibitor MLN4924 is detrimental for endothelial barrier function, due to accumulation of RhoB and the consequent induction of contractility. Here we analyzed the effect of pharmacological activation of Cullin RING ligases on endothelial barrier integrity in vitro and in vivo. CSN5i-3 induced endothelial barrier disruption and increased macromolecule leakage in vitro and in vivo. Mechanistically, CSN5i-3 strongly induced the expression and activation of RhoB and to lesser extent of RhoA in endothelial cells, which enhanced cell contraction. Elevated expression of RhoGTPases was a consequence of activation of the NF-κB pathway. In line with this notion, CSN5i-3 treatment decreased IκBα expression and increased NF-κB-mediated ICAM-1 expression and consequent adhesion of neutrophils to endothelial cells. This study shows that sustained neddylation of Cullin RING-ligases leads to activation the NF-κB pathway in endothelial cells, elevated expression of RhoGTPases, Rho/ROCK-dependent activation of MLC and disruption of the endothelial barrier.

Indexed as

InflammationAnimalsCOP9 Signalosome ComplexCyclopentanesEndothelium, VascularGene Expression RegulationGreen Fluorescent ProteinsHEK293 CellsHumansHuman Umbilical Vein Endothelial CellsIntercellular Adhesion Molecule-1Intracellular Signaling Peptides and ProteinsNeutrophilsNF-KappaB Inhibitor alphaNF-kappa B p50 SubunitPeptide HydrolasesCOP9 Signalosome ComplexCOPS5 protein, humanCyclopentanesGreen Fluorescent ProteinsICAM1 protein, humanIntercellular Adhesion Molecule-1Intracellular Signaling Peptides and ProteinsNF-KappaB Inhibitor alphaNF-kappa B p50 SubunitNFKB1 protein, humanPeptide HydrolasespevonedistatPyrimidinesrhoA GTP-Binding ProteinRHOA protein, humanrho-Associated KinasesrhoB GTP-Binding ProteinRHOB protein, humanUbiquitin

Identifiers

PMID31148579
PMCPMC6544660
OpenAlexW2947697199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.